Trials / Unknown
UnknownNCT00022958
Expanded Access Study of Iodine-131 Anti-B1 Antibody
Expanded Access Study of Iodine-131 Anti-B1 Antibody for Relapsed/Refractory Low-Grade and Transformed Low-Grade Non-Hodgkin's Lymphoma
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Corixa Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to make Iodine-131 Anti-B1 Antibody more broadly available to patients. Secondary endpoints of the study will be to obtain additional information on the efficacy and safety of Iodine-131 Anti-B1 Antibody.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Iodine-131 Anti-B1 Antibody |
Timeline
- Start date
- 1998-09-01
- First posted
- 2001-08-20
- Last updated
- 2005-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00022958. Inclusion in this directory is not an endorsement.